中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共6条，第1-6条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
A randomized, controlled, multi-center, open-label study of adjuvant nab-paclitaxel plus S-1 (AS) versus capecitabine plus oxaliplatin (CapeOX) for stage III gastric cancer after D2 resection. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yu, Pengfei;  Du, Yian;  Xu, Zhiyuan;  Yang, Litao;  Ying, Jieer;  Wang, Yongxiang;  Chen, Ping;  Wei, Yunhai;  Xu, Hongtao;  Xu, Nong;  Cheng, Xiangdong
收藏  |  浏览/下载：47/0  |  提交时间：2022/12/23
Prolonged overall survival observed in patients with locally advanced gastric cancer receiving prophylactic simplified heated intraperitoneal chemotherapy after D2 surgery. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Cheng, Junchi;  Yang, Yunshan;  Zhong, Haijun
收藏  |  浏览/下载：45/0  |  提交时间：2022/01/10
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying;  Guo, Weijian;  Jia, Tongfu;  Zhao, Qun;  Zhang, Guifang;  He, Yifu;  Zhong, Haijun;  Ba, Yi;  Lin, Xiaoyan;  Yang, Jianwei;  Zhao, Jun;  Bai, Yuxian;  Sun, Guogui;  Wu, Yongjuan;  Wang, Meng;  Sun, Ying
收藏  |  浏览/下载：61/0  |  提交时间：2022/01/10
Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Guo, Weijian;  Zhu, Xiaodong;  Huang, Mingzhu;  Wang, Yusheng;  Chen, Zhiyu;  Feng, Wanjing;  He, Yifu;  Zhang, Xiaowei;  Liu, Xin;  Wang, Chenchen;  Zhang, Wen;  Ying, Jieer;  Wu, Jun;  Yang, Lei;  Qin, Yanru;  Zhao, Xiaoying;  Li, Wenhua;  Zhang, Zhe;  Qiu, Lixin;  Wang, XiaoFeng
收藏  |  浏览/下载：56/0  |  提交时间：2022/01/10
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying;  Guo, Weijian;  Jia, Tongfu;  Jiang, Da;  Zhang, Guifang;  He, Yifu;  Zhong, Haijun;  Ba, Yi;  Lin, Xiaoyan;  Yang, Jianwei;  Zhao, Jun;  Bai, Yuxian;  Wu, Xiangyuan;  Gao, Feng;  Sun, Ying;  Hou, Zhiguo
收藏  |  浏览/下载：58/0  |  提交时间：2022/01/10
The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Xu, Jianming;  Zhang, Yun;  Wu, Jun;  Xu, Nong;  Ying, Jieer;  Xiang, Xiaojun;  Zhang, Yanqiao;  Wang, Jianhong;  Zhao, Rusen;  Ye, Feng;  Wu, Qiong;  Guo, Baohong;  Liu, Yuchen;  Liu, Juan;  Xing, Shuning;  Xu, Ting
收藏  |  浏览/下载：49/0  |  提交时间：2022/01/10